Arnout Ploos Van Amstel
Executive in Residence
Arnout is an Executive Leader in Life Sciences/Biotech with more than 30 years of business and operations experience in a wide variety of leadership positions and geographies. He is passionate about converting science and products into sustainable value for customers and patients. Arnout masters the design and execution of fully integrated Development-Medical-Commercial-Access strategies. Arnout is the Founder of Apaxcel Life Sciences GmbH, a Consulting Company that supports biopharma customers in Creating Strategies that Accelerate Outcomes. Previously, he led Novartis’ Global Business Unit Immunology-Hepatology-Dermatology (IHD “Biotech within Novartis”, ~$5Bn) and was responsible for assets from early clinical development to late-stage commercialization. Regular portfolio enrichments were added through business development deals. Arnout is the driver behind the success of the game-changing biologic Cosentyx (close to $1bn in Q1 2020), the best Novartis launch ever. He created Xolair in the skin disease CSU from scratch, generating blockbuster potential, and built "orphan blockbusters" like Ilaris in auto-inflammatory diseases. IHD further included Transplantation and the Liver Diseases/NASH portfolio. Prior to the BU Head role, he enjoyed a global career at Wyeth Pharmaceuticals and Novartis with positions of increasing responsibilities, among others General Management roles in the US, Canada, Greece, and in the Netherlands. Arnout was born and raised in the Netherlands and holds a Master’s degree in Economics from the University of Groningen.